‘A victim of its own success’: inside the great Ozempic shortage

Australian Financial Review

26 May 2023 - The drug is approved in Australia to treat type 2 diabetes but people have flocked to it for weight loss. 

That’s raising some hard questions about who should receive it and why.

Read Australian Financial Review article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Australia , Supply